Document is current

Aggressive B cell Lymphoma: Optimal Therapy for MYC-positive, Double-Hit, and Triple-Hit DLBCL

Crossref DOI link: https://doi.org/10.1007/s11864-015-0374-0

Published Online: 2015-12-03

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy